Sichuan Huiyu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Sichuan Huiyu Pharmaceutical has a total shareholder equity of CN¥3.9B and total debt of CN¥675.3M, which brings its debt-to-equity ratio to 17.4%. Its total assets and total liabilities are CN¥5.0B and CN¥1.2B respectively. Sichuan Huiyu Pharmaceutical's EBIT is CN¥87.6M making its interest coverage ratio -1.7. It has cash and short-term investments of CN¥2.7B.
Key information
17.4%
Debt to equity ratio
CN¥675.30m
Debt
Interest coverage ratio | -1.7x |
Cash | CN¥2.72b |
Equity | CN¥3.88b |
Total liabilities | CN¥1.17b |
Total assets | CN¥5.05b |
Recent financial health updates
Here's Why Sichuan Huiyu Pharmaceutical (SHSE:688553) Can Manage Its Debt Responsibly
Sep 29Sichuan Huiyu Pharmaceutical (SHSE:688553) Has A Pretty Healthy Balance Sheet
Jun 07Recent updates
Sichuan Huiyu Pharmaceutical's (SHSE:688553) Promising Earnings May Rest On Soft Foundations
Nov 02Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE:688553) Stock Catapults 38% Though Its Price And Business Still Lag The Market
Oct 29Here's Why Sichuan Huiyu Pharmaceutical (SHSE:688553) Can Manage Its Debt Responsibly
Sep 29Sichuan Huiyu Pharmaceutical (SHSE:688553) Has A Pretty Healthy Balance Sheet
Jun 07Sichuan Huiyu Pharmaceutical Co., Ltd.'s (SHSE:688553) 33% Share Price Surge Not Quite Adding Up
Mar 07Financial Position Analysis
Short Term Liabilities: 688553's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688553's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥44.5M).
Debt to Equity History and Analysis
Debt Level: 688553 has more cash than its total debt.
Reducing Debt: 688553's debt to equity ratio has reduced from 24.8% to 17.4% over the past 5 years.
Debt Coverage: 688553's debt is well covered by operating cash flow (30.9%).
Interest Coverage: 688553 earns more interest than it pays, so coverage of interest payments is not a concern.